178 related articles for article (PubMed ID: 16986109)
1. Determination of the maturity and functionality of tumor vasculature by MRI: correlation between BOLD-MRI and DCE-MRI using P792 in experimental fibrosarcoma tumors.
Baudelet C; Cron GO; Gallez B
Magn Reson Med; 2006 Nov; 56(5):1041-9. PubMed ID: 16986109
[TBL] [Abstract][Full Text] [Related]
2. The role of vessel maturation and vessel functionality in spontaneous fluctuations of T2*-weighted GRE signal within tumors.
Baudelet C; Cron GO; Ansiaux R; Crokart N; DeWever J; Feron O; Gallez B
NMR Biomed; 2006 Feb; 19(1):69-76. PubMed ID: 16411170
[TBL] [Abstract][Full Text] [Related]
3. Cluster analysis of DCE-MRI data identifies regional tracer-kinetic changes after tumor treatment with high intensity focused ultrasound.
Jacobs I; Hectors SJ; Schabel MC; Grüll H; Strijkers GJ; Nicolay K
NMR Biomed; 2015 Nov; 28(11):1443-54. PubMed ID: 26390040
[TBL] [Abstract][Full Text] [Related]
4. Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model.
Park HS; Han JK; Lee JM; Kim YI; Woo S; Yoon JH; Choi JY; Choi BI
Korean J Radiol; 2015; 16(5):1029-37. PubMed ID: 26357497
[TBL] [Abstract][Full Text] [Related]
5. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
[TBL] [Abstract][Full Text] [Related]
6. Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.
Delrue LJ; Casneuf V; Van Damme N; Blanckaert P; Peeters M; Ceelen WP; Duyck PC
MAGMA; 2011 Aug; 24(4):225-32. PubMed ID: 21567161
[TBL] [Abstract][Full Text] [Related]
7. Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density.
Chen J; Chen C; Xia C; Huang Z; Zuo P; Stemmer A; Song B
Abdom Radiol (NY); 2018 Jun; 43(6):1393-1403. PubMed ID: 28939963
[TBL] [Abstract][Full Text] [Related]
8. Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia?
Baudelet C; Ansiaux R; Jordan BF; Havaux X; Macq B; Gallez B
Phys Med Biol; 2004 Aug; 49(15):3389-411. PubMed ID: 15379021
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images.
Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK
Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783
[TBL] [Abstract][Full Text] [Related]
10. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.
Lüdemann L; Nafz B; Elsner F; Grosse-Siestrup C; Meissler M; Kaufels N; Rehbein H; Persson PB; Michaely HJ; Lengsfeld P; Voth M; Gutberlet M
Invest Radiol; 2009 Mar; 44(3):125-34. PubMed ID: 19151609
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
12. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.
Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y
J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive monitoring of microvascular changes with partial irradiation using dynamic contrast-enhanced and blood oxygen level-dependent magnetic resonance imaging.
Lin YC; Wang JJ; Hong JH; Lin YP; Lee CC; Wai YY; Ng SH; Wu YM; Wang CC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1367-74. PubMed ID: 23195777
[TBL] [Abstract][Full Text] [Related]
14. Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T.
Weidensteiner C; Rausch M; McSheehy PM; Allegrini PR
J Magn Reson Imaging; 2006 Sep; 24(3):646-56. PubMed ID: 16878308
[TBL] [Abstract][Full Text] [Related]
15. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.
Ceelen W; Smeets P; Backes W; Van Damme N; Boterberg T; Demetter P; Bouckenooghe I; De Visschere M; Peeters M; Pattyn P
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1188-96. PubMed ID: 16457965
[TBL] [Abstract][Full Text] [Related]
17. How does blood oxygen level-dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors?
Baudelet C; Gallez B
Magn Reson Med; 2002 Dec; 48(6):980-6. PubMed ID: 12465107
[TBL] [Abstract][Full Text] [Related]
18. Vessel wall and adventitial DCE-MRI parameters demonstrate similar correlations with carotid plaque microvasculature on histology.
van Hoof RHM; Vöö SA; Sluimer JC; Wijnen NJA; Hermeling E; Schreuder FHBM; Truijman MTB; Cleutjens JPM; Daemen MJAP; Daemen JH; van Oostenbrugge RJ; Mess WH; Wildberger JE; Heeneman S; Kooi ME
J Magn Reson Imaging; 2017 Oct; 46(4):1053-1059. PubMed ID: 28152245
[TBL] [Abstract][Full Text] [Related]
19. A reference agent model for DCE MRI can be used to quantify the relative vascular permeability of two MRI contrast agents.
Cárdenas-Rodríguez J; Howison CM; Matsunaga TO; Pagel MD
Magn Reson Imaging; 2013 Jul; 31(6):900-10. PubMed ID: 23583323
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
